GCP
RCPI

GSA Capital Partners’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

GSA Capital Partners’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,001
Closed -$10K – 2409
2015
Q1 		$10K Hold
4,001
– – ﹤0.01% 2081
2014
Q4 		$18K Hold
4,001
– – ﹤0.01% 1653
2014
Q3 		$28K Buy
4,001
+2,276
+132% +$22.5K ﹤0.01% 1673
2014
Q2 		$25K Buy
+1,725
New +$29.9K ﹤0.01% 1767

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GSA Capital Partners's RCPI Position: Q2 2015 in Review

GSA Capital Partners sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 4,001 shares — an estimated $10K sold.

GSA Capital Partners first reported a position in RCPI in Q2 2014 and held it in 4 quarters. The position peaked at $28K in Q3 2014. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • GSA Capital Partners reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • GSA Capital Partners sold 4,001 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $10K.
  • GSA Capital Partners first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • GSA Capital Partners's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $28K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.